Clinical Trial Update: A Trial Comparing Three Different Treatment Options for Adults With Low-Risk Myelodysplasia and Anemia (A MyeloMATCH Treatment Trial) [Phase 2]

View source ↗

Summary

Phase 2 trial comparing three treatment options for adults with low-risk myelodysplastic syndromes and anemia; status is NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Myelodysplastic Syndrome | Phase 2 | Status: NOT_YET_RECRUITING